News

Published on 6 Nov 2024 on GuruFocus.com · via Yahoo Finance

What To Expect From ADC Therapeutics SA (ADCT) Q3 2024 Earnings


Article preview image

ADC Therapeutics SA (NYSE:ADCT) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus...

NYSE.ADCT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What To Expect From ADC Therapeutics SA (ADCT) Q3 2024 Earnings

ADC Therapeutics SA (NYSE:ADCT) is set to release its Q3 2024 earnings on Nov 7, 2024. The consen...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

ADC Therapeutics SA (NYSE:ADCT) Shares Could Be 50% Below Their Intrinsic Value...

Key Insights Using the 2 Stage Free Cash Flow to Equity, ADC Therapeutics fair value estimate is ...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)

On May 7, 2024, Ameet Mallik, Chief Executive Officer of ADC Therapeutics SA (NYSE:ADCT), sold 29...

GuruFocus.com via Yahoo Finance 10 May 2024

ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This...

Last week, you might have seen that ADC Therapeutics SA (NYSE:ADCT) released its quarterly result...

Simply Wall St. via Yahoo Finance 9 May 2024

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript May 6, 2024 ADC Therapeutics SA ...

Insider Monkey via Yahoo Finance 7 May 2024

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.56 per share in line with the Zac...

Zacks via Yahoo Finance 6 May 2024

ZYNLONTA shows high response rate in lymphoma trial By Investing.com

ADC Therapeutics SA (NYSE:ADCT) reported promising initial results from a Phase 2 clinical trial ...

Investing.com 6 May 2024

ADC Therapeutics Jumps on Earnings Beat

ADC Therapeutics Jumps on Earnings Beat

Investing.com 6 May 2024

US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results

There's been a notable change in appetite for ADC Therapeutics SA (NYSE:ADCT) shares in the week ...

Simply Wall St. via Yahoo Finance 16 Mar 2024

ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript

ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript March 13, 2024 ADC Therapeutics ...

Insider Monkey via Yahoo Finance 15 Mar 2024